Synthetic molecule chokes TB growth

A new drug candidate has shown promising signs in treating tuberculosis. The synthetic molecule is effective in mice and bears no similarity to existing TB drugs, many of which have become inadequate as drug-resistant bacterial strains have developed. If it is shown to be safe and effective in humans, it could help to combat a disease that killed 1.4 million people in 2011.